https://ilomastatinhibitor.com..../ocular-signs-linked
IrAEs affected 159% of fifty patients. A multivariate analysis revealed independent factors associated with irAE occurrence: squamous cell carcinoma (P=0.0021, OR 230, 95% CI 114-465), anti-PD-1 plus anti-CTLA-4 regimens (P0.001, OR 2210, 95% CI 560-872, and a neutrophil-to-lymphocyte ratio (NLR) of less than 3 (P0.001, OR 291, 95% CI 135-627). Potential predictors for irAEs arising from induction immunochemotherapy in NSCLC patients include squam
Like
Comment
Share
